Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
BackgroundMyelodysplastic neoplasms (MDS) are characterized by ineffective hematopoiesis, peripheral blood cytopenias, and an increased risk of progression to acute myeloid leukemia. One of the main treatment goals is improving quality of life (QoL), particularly for patients with lower-risk MDS (LR...
Saved in:
Main Authors: | Esther Natalie Oliva, Shien Guo, Jennifer Lord-Bessen, Aylin Yucel, Roberto Latagliata, Massimo Breccia, Giuseppe A. Palumbo, Grazia Sanpaolo, Marta Riva, Valeria Santini, Uwe Platzbecker, Guillermo Garcia-Manero, Pierre Fenaux, Christopher G. Pelligra |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1507854/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes
by: Baobing Zhao, et al.
Published: (2019-03-01) -
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma
by: Qiangan Jing, et al.
Published: (2025-01-01) -
The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2024-12-01) -
Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
by: Zdenek Krejcik, et al.
Published: (2025-01-01) -
STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)